Erlotinib hydrochloride is a pharmaceutical raw material used in the manufacturing of medicines. It is a salt form of erlotinib, a compound that acts as an inhibitor of the epidermal growth factor receptor (EGFR).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 183319-69-9
Erlotinib
pharmaceutical raw material
Ethyl 4-(8-chloro-3-hydroxy-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
pharmaceutical raw material
Abarelix
pharmaceutical raw material
Befotertinib
pharmaceutical raw material
Ethacridine lactate
pharmaceutical raw material
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline
pharmaceutical intermediate
Neptinib
pharmaceutical raw material
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
GTTBEUCJPZQMDZ-UHFFFAOYSA-N
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl